outlook conserv reason optim reiter buy last week
report adjust ep versu consensu miss
partial due lower-than-expect organ sale tie weaker
manufactur activ posit note state weak
industri busi worsen gm yoy
estim given lower volum despit held om flat
yoy order flat improv
help larg scienc order small
restructur provid save would
buyer weak view resili compani oper
difficult environ bright outlook volum return
proven track record manag industry-lead margin cycl
think deliv progress weak industri activ
get wors easier comp along order roll
provid relief look sever decent-s deal may
point question focus follow weak
guidanc understand assumpt reach full-year outlook
flat sale impli modest improv impact lap
multi-year growth initi repeat detail around
md acquisit pipelin address recent weak
ep walk includ higher tax variabl incent
compani narrow initi guidanc flat
organ sale guidanc lower expect
although face tough comp sound conserv
assumpt consid industri worsen see improv
like progress given easier comp larg order roll
restructur save better volum intak
meter read-across buy
buy instrument sell pumps/valv
mueller buy valves/clamp fire safeti
valuat rais pt assum
ep exit roll forward valuat methodolog
prompt higher pt note capac
assum ad leverag remain key alloc prioriti
chang made note
buy chang
page analyst certif
perform rel
oper busi
valv meter fluidic system use
industri life scienc safeti energi
profit loss summari
growth margin
structur advantag compet nich market
player give structur advantag price
power grow sale bp market coupl
price leverag gener durabl cash flow
cycl compani reinvest like led product
underappreci margin expans continu surpris
result capit expect deploy
next month believ may fuel share price
disciplin believ
fundament point higher believ continu
outperform next month given resili core
busi believ consensu overlook strong order
trend oper control resili portfolio vs
innov meet eye believ get
enough credit innov advanc make
global author fluidic optic manufactur
highli trust product use area like life scienc
valuat pt assum adj ep
chang net debt
average cost debt
risk invest thesi
sale exposur half total sale
outsid face fx rate risk credit market volatil
integr acquisit compani grown
histor acquisit may perform plan
failur integr properli could result loss earn
exposur industri cycl mani busi expos
 global industri cycl slowdown either could result
lower demand product lead declin earn
figur corp glanc
sale busi segment
sale busi segment
sale busi segment
sale busi segment
sale
sale
sale
sale
sale end market
sale end market
sale end market
sale end market
mostli mid-stream expos
total
total
total
total
sale int
sale int
sale int
sale int
meter wholesal retail dist
fluidic optic integr fluidic medic
oil aviat refuel industri meter
pump valv fire rescu specialti vehicl
termin autom manag inv transact
seal seal adv seal hazard duti
band-it banding/clamp auto transport
valv specialti valv chem energi sanitari
fluid control cosmet deterg food pharma gast motor medic environ electron
dispens equip use mix paint
water meter tech flow monitor wastewat micropump medic chem proc textil pharma
retail commerci biz suppli auto
proc lab equip pharma food
purif mfg semi wastewat treatment
proc solut powder prepack food pharma
person care food bev pharma biotech
awg fit dingle hurst jaw life
ag banjo fmt sale
pump small compressor use oil dist
vacuum pump compressor
corob spa dispens mix paint
gooch housego electro-opt photon
mostli distributor
mostli direct oe distribut
mostli distributor
custom sale across segment
larg custom st
sale
figur organ sale segment
figur guidanc
price target assum adjust ep impli ev/ebitda
adjust ebitda pt impli yield indic
capit expect deploy next twelv month believ
incorpor valuat warrant premium price-to-earnings
trade rang sinc averag price-to-earnings last five
year ev/ebitda trade rang averag
ev/ebitda multipl last five year
grow
bp
contract
lsd
expand
sale exposur half total sale outsid
expect intern oper continu signific face
exchang rate risk credit market volatil geopolit risk
integr acquisit compani histor grown
 guarante abl success identifi suitabl
candid complet propos acquisit integr acquir busi
exist oper furthermor acquisit may perform plan failur
integr properli could result loss earn
exposur industri cycl well-diversifi mani busi
product expos global industri cycl slowdown either
could result lower demand product lead declin earn
competit requir continu invest maintain technolog
advantag given advanc system product need maintain qualiti
standard effici distribut network failur could result custom
churn possibl loss futur busi new competit alway potenti
threat could pose risk price loss market share time larger
competitor access capit may also becom competit could
neg affect futur margin earn
revenu
revenu
revenu
sale busi
revenu
loss earli extinguish debt
provis tax benefit
net loss disc op
net incom cont op
net incom cont op
net incom cont op
net incom cont op
